H.R. 3415
Referred to CommitteeReal-Time Beneficiary Drug Cost Bill
Latest Action
Referred to the Subcommittee on Health.
6/24/2019 • House
Summary
Real-Time Beneficiary Drug Cost Bill
This bill provides statutory authority for certain provisions of the Centers for Medicare & Medicaid Services rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.
Introduced in House • 6/21/2019
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (5)
Party Breakdown
Sponsor
Cosponsors (4)
Bill Journey
Originated in the House
Introduced
June 21, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (6)
H.R. 19
Lower Costs, More Cures Act of 2019
H.R. 2115
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
H.R. 3408
Shop Rx Act of 2019
H.R. 3417
BETTER Act of 2019
S. 3129
Lower Costs, More Cures Act of 2019
H.R. 2296
More Efficient Tools to Realize Information for Consumers Act